Authors: Puangmalai, Nicha
Somani, Alyma
Thangnipon, Wipawan
Ballard, Clive
Broadstock, Martin
Title: A genetically immortalized human stem cell line: a promising new tool for Alzheimer's disease therapy
Language (ISO): en
Abstract: Amyloid-β peptides and hyper-phosphorylated tau are the main pathological hallmarks of Alzheimer’s disease (AD). Given the recent failure of several large-scale clinical trials and the lack of disease-modifying pharmacological treatments, there is an urgent need to develop alternative therapies. A clinical grade human CTX0E03 neural stem cell line has recently passed phase I trials in people with stroke. However, this cell line has not been investigated in other neurodegenerative disorders. This study investigates the survival of CTX0E03 cells under conditions based on the underlying AD pathology. Cell viability assays showed a concentration dependence of this cell line to the toxic effects of Aβ1-42, but not Aβ1-40, and okadaic acid, a phosphatase 2A inhibitor. Notably, CTX0E03 cell line displayed toxicity at concentrations significantly higher than both rat neural stem cells and those previously reported for primary cultures. These results suggest CTX0E03 cells could be developed for clinical trials in AD patients.
Subject Headings: Alzheimer’s disease
cell viability
CTX0E03 cell line
neural stem cell
okadaic acid
oligomeric amyloid-β
Issue Date: 2015-10-21
Rights link:
Appears in Collections:Original Articles

Files in This Item:
File Description SizeFormat 
Thangnipon_21102015_proof.pdfDNB428.96 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons